Physician profile
Nirav Patel
NPI 1003171109
$1,673.61
in general payments reported to CMS, 2019-2025
21 companies · $76.06 in 2025
The $76.06 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2020: $659 · 2021: $162 · 2022: $25.70 · 2023: $42.25 · 2024: $224 · 2025: $76.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $342.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $436.42 | 2019-2025 | |
| Abbott Laboratories | $216.74 | 2021-2024 | Coroflow, Cardiomems |
| Portola Pharmaceuticals, LLC | $214.30 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $119.67 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $94.55 | 2020-2021 | |
| Lilly USA, LLC | $76.59 | 2019-2021 | |
| Dermira, INC. | $68.09 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $67.97 | 2019-2020 | |
| Genentech USA, INC. | $58.13 | 2019-2020 | |
| Galderma Laboratories, L.P. | $44.09 | 2019-2021 | |
| Genzyme Corporation | $35.45 | 2019-2020 | |
| Almirall LLC | $33.77 | 2020 | |
| Pfizer INC. | $33.36 | 2019-2021 | |
| Leo Pharma INC. | $32.74 | 2020 | |
| Sun Pharmaceutical Industries INC. | $31.05 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $30.09 | 2020 | |
| Solta Medical, A Division of Bausch Health US, LLC | $19.74 | 2020 | |
| Vyne Pharmaceuticals INC. | $19.27 | 2020 | |
| Allergan, INC. | $18.99 | 2021 | |
| Prugen, INC. Pharmaceuticals | $11.91 | 2019 | |
| Epi Health, LLC | $10.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirav Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.